Average Co-Inventor Count = 10.81
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (40 from 1,974 patents)
2. Biovitrum Ab (3 from 55 patents)
3. Array Biopharma Inc. (2 from 329 patents)
40 patents:
1. 12473289 - Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
2. 12459932 - KIF18A inhibitors
3. 12054476 - KIF18A inhibitors
4. 11548903 - Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
5. 11021493 - 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
6. 10947223 - Substituted oxazines as beta-secretase inhibitors
7. 10889579 - Thiazine derivatives as β-secretase inhibitors and methods of use
8. 10246429 - Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
9. 9725469 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use
10. 9718803 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors
11. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use
12. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
13. 9493459 - Azetidine and piperidine compounds useful as PDE10 inhibitors
14. 9303028 - Azetidine and piperidine compounds useful as PDE10 inhibitors
15. 9296734 - Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use